Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
25 /100
COMPONENT-LIMITED
Score updated Nov 20, 2026

ABCL — AbCellera Biologics Inc. Dilution Risk Tracker

Track ABCL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — higher scores indicate higher risk of share dilution.

Not financial advice. Do your own research before making any investment decisions.

Track ABCL — Get alerts when the score changes →

As of November 20, 2026, AbCellera Biologics Inc. (ABCL) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. AbCellera Biologics Inc. has a market capitalization of $3.42B, 326.62M shares outstanding, 140 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

Offering Ability
20
Cash Runway
40
Float Risk—
Warrant Exposure
15
Convertible Debt
15

Dilution Forecast

Forecast data not available for this ticker.

Market Data

Market Cap$3.42B
Shares Outstanding326.62M
Float206.94M
Cash$163.80M
Debt$190.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore25/100DilutionWatch score record
Shares Outstanding326.62MVerified float table or market cache
Public Float206.94MVerified float table or market cache
Market Cap$3.42BMarket data cache
Cash Runway15.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: FORM 4 5.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

ABCL SEC Filing Activity — Last 12 Months

Shares outstanding reported by ABCL on the cover page of its latest 10-K/10-Q: 326.62M as of November 04, 2026.

DilutionWatch recorded 1 registration or prospectus document for ABCL (the filings through which shares are offered) in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
424B5prospectus supplement (ATM / shelf takedown)1Aug 11, 2026
8-Kcurrent report (material event)2Nov 09, 2026
10-Qquarterly report1Nov 09, 2026
SC 13G/Aamended passive >5% holder filing1Nov 13, 2026
4insider transaction7Nov 16, 2026

Institutional Holdings

QoQ: ↑ 31.4% shares (2026Q1 vs prior)
140 institutional holders · 142.73M shares
#1 BAKER BROS. ADVISORS LP 30.28M shares
#2 Capital World Investors 13.36M shares
#3 TWO SIGMA INVESTMENTS, LP 10.56M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest29.02M
Days to Cover8.5
% of Float14.0%
FINRA data as of Oct 30, 2026

Recent SEC Activity

Form 4 INSIDER TRANSACTION 2026-11-13
Form 4 INSIDER TRANSACTION 2026-11-13
Form 4 INSIDER TRANSACTION 2026-11-13
Form 4 INSIDER TRANSACTION 2026-11-13
Form 4 INSIDER TRANSACTION 2026-11-12
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ABCL Dilution Snapshot

AbCellera Biologics Inc. (ABCL) has a DilutionScore of 25/100, rated Low dilution risk. Score date: November 20, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ABCL's DilutionScore is currently 25/100 (Low risk), with 1 score change tracked over 89 days. The score deteriorated from 35/100 (Medium risk).

Period Score Risk Level Duration
Nov 16 – Nov 20, 202625/100LOW5 days
Aug 24 – Nov 15, 202635/100MEDIUM84 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ABCL shares outstanding have increased 6.5% from 306.61M (Nov 2026) to 326.62M (Nov 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Nov 21, 2026326.62M206.94M—
Nov 16, 2026326.62M206.94M—
Nov 10, 2026306.61M206.94M—

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ABCL Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ABCL files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ABCL — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 7,727+ tracked stocks →

Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for ABCL
ABCL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.